Tonix Pharmaceuticals Holding Corp. Annual Cost of Revenue in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Cost of Revenue history and growth rate for 2023.
  • Tonix Pharmaceuticals Holding Corp. Cost of Revenue for the quarter ending September 30, 2024 was $1.56M, a 34.5% decline year-over-year.
Cost of Revenue, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.74M Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.